Vertebroplasty And Kyphoplasty Market Report Scope & Overview:

The Vertebroplasty And Kyphoplasty Market was valued at USD 0.94 Billion in 2025 and is expected to reach USD 1.62 Billion by 2035, growing at a CAGR of 5.60% from 2026 to 2035.

The Vertebroplasty and Kyphoplasty Market experiences a continuous expansion as a result of an increase in the incidence rate of osteoporotic vertebral compression fractures globally, the increasing demand for minimally invasive spine surgery procedures with same-day hospital discharge, and the constant innovations within bone cement technology and delivery equipment that improve the procedure’s safety level. Vertebroplasty and kyphoplasty are common percutaneous procedures that involve stabilization of fractured vertebrae, restoration of the vertebral body height and alleviation of chronic back pain. The procedures offer a highly effective alternative to open spine surgery procedure for hospitals and ambulatory surgery centers, in addition to shorter recovery periods and decreased post-surgery complications rate.

In 2026, Medtronic and Merit Medical Systems strengthened their business relationship to further distribute the FDA-approved ViaVerte vertebral augmentation system.

Vertebroplasty And Kyphoplasty Market Trends:

• Rising integration of AI-assisted navigation systems is improving needle-puncture accuracy and reducing cement leakage during vertebral augmentation procedures.

• Growing adoption of bioactive and radiopaque bone cement formulations is reshaping surgeon preference away from conventional PMMA in select clinical cases.

• Expanding use of vertebral augmentation in oncology settings is broadening procedure volumes beyond traditional osteoporotic fracture indications.

• Increasing migration of procedures toward ambulatory surgical centers is reducing per-case costs and reinforcing outpatient care models.

• Strategic collaborations between device manufacturers and distribution partners are strengthening bundled cement-and-balloon kit offerings worldwide.

U.S. Vertebroplasty And Kyphoplasty Market Outlook:

The U.S. Vertebroplasty And Kyphoplasty Market was valued at USD 0.32 Billion in 2025 and is projected to reach USD 0.52 Billion by 2035, growing at a CAGR of 5.10% during 2026–2035.

The major players in terms of device manufacturing and the major chains of hospitals in the country are increasing their adoption rate of vertebral augmentation procedures. There are several factors behind this increasing trend, which include already existing coverage of the procedures through Medicare and other third-party payers, aging demographics in the country, and the preference for earlier surgical treatment following the diagnosis of osteoporotic fractures. As the case numbers for vertebral augmentation procedures move from the traditional hospital settings to ASCs, due to the favorable reimbursements for balloon kyphoplasty procedures and increasing fellowship training of interventional spine specialists, there is an increase in the need for more advanced vertebroplasty and kyphoplasty systems.

In January 2026, Xelite Biomed received U.S. FDA clearance for its SuperM-Fix Spinal Bone Cement, expanding the range of domestically available cement options for vertebral augmentation procedures performed across U.S. hospitals and ambulatory surgical centers.

Vertebroplasty And Kyphoplasty Market Segment Analysis:

• By Product Type, Kyphoplasty Devices dominated the Vertebroplasty And Kyphoplasty Market with a 64.20% share in 2025, while Vertebroplasty Devices is the fastest-growing product type segment with a CAGR of 6.15% from 2026–2035.

• By Bone Cement Material, PMMA dominated the Vertebroplasty And Kyphoplasty Market with a 70.30% share in 2025, while Other Materials is the fastest-growing bone cement segment with a CAGR of 7.10% from 2026–2035.

• By Application, Osteoporotic Vertebral Compression Fractures dominated the Vertebroplasty And Kyphoplasty Market with a 57.40% share in 2025, while Spinal Metastases is the fastest-growing application segment with a CAGR of 6.85% from 2026–2035.

• By Surgical Approach, Transpedicular dominated the Vertebroplasty And Kyphoplasty Market with a 68.90% share in 2025, while Extrapedicular is the fastest-growing surgical approach segment with a CAGR of 6.40% from 2026–2035.

• By End User, Hospitals dominated the Vertebroplasty And Kyphoplasty Market with a 60.80% share in 2025, while Ambulatory Surgical Centers is the fastest-growing end-user segment with a CAGR of 6.60% from 2026–2035.

By Product Type, Kyphoplasty Devices dominated the Vertebroplasty And Kyphoplasty Market, while Vertebroplasty Devices is the fastest-growing segment.

The Kyphoplasty Devices segment was the most prominent contributor and captured the largest share of 64.20% in the Vertebroplasty and Kyphoplasty Market. Kyphoplasty has established itself as the leading product type due to the fact that this technique relies on a balloon to restore the vertebral height while posing minimal risks of cement leakage in contrast to vertebroplasty, and offering substantial benefits in sagittal correction and pain reduction. The popularity of kyphoplasty is driven by the possibility to form a cavity prior to cement introduction which ensures predictability of doses and pressure in the process of treatment.

The Vertebroplasty Devices segment is expected to witness the highest CAGR of 6.15% during the forecast period 2026-2035. Growing adoption in cost-sensitive and emerging healthcare markets is propelling segment growth on account of the shorter procedure time, lower device complexity, and reduced capital equipment requirements associated with cement-only stabilization compared with balloon-assisted techniques. Rising use of vertebroplasty for acute pain palliation in oncology patients with vertebral metastases, where rapid stabilization is prioritized over height restoration, is further supporting above-average growth for this segment.

By Bone Cement Material, PMMA dominated the Vertebroplasty And Kyphoplasty Market, while Other Materials is the fastest-growing segment.

PMMA type accounted for the 70.30% share of the Vertebroplasty and Kyphoplasty Market in 2025. Polymethyl methacrylate has been traditionally accepted as the gold standard, thanks to its proven mechanical strength and predictable polymerization properties along with many decades of experience in its use by spine surgeons and interventional radiologists around the world. PMMA’s viscosity and setting time characteristics continue to be improved to reduce the possibility of extrusion and at the same time retain the required compressive strength required for vertebral bone loading. PMMA cement kits are still universally compatible with the cannulae, mixing equipment, and inflation devices used in hospitals and ambulatory surgery centers.

The Other Materials market comprising bioactive and calcium-containing cement substitutes would exhibit the highest rate of growth during 2026-2035 with a CAGR of 7.10%. Growing interest from the surgeons in osteoconductive materials such as strontium hydroxyapatite and calcium phosphate hybrid cements, due to their ability to promote bone bonding and resorption, would favor the use of these substitutes among patients requiring permanent skeletal integration. Some spine centers are switching to the use of bioactive cement substitutes for patients younger or suffering from osteoporosis based on evidence of less inflammatory response than the conventional acrylic cement.

By Application, Osteoporotic Vertebral Compression Fractures dominated the Vertebroplasty And Kyphoplasty Market, while Spinal Metastases is the fastest-growing segment.

Osteoporotic Vertebral Compression Fractures was the leading segment in the Vertebroplasty and Kyphoplasty Market in 2025, contributing 57.40% of the market’s total value. The osteoporotic fractures continue to be the largest application area due to the increasing size of the world’s aged population suffering from decreased bone mineral density and, as a consequence, experiencing over a million cases of vertebral compression fractures annually. In addition, the growth of vertebral augmentation in patients unresponsive to conservative treatment of pain management after four to six weeks since the fracture is supported by clinical guidelines, providing a stable demand in procedures at hospitals and ambulatory settings.

The Spinal Metastases segment is expected to register the fastest CAGR of 6.85% during the forecast period 2026-2035. Growing survival rates among cancer patients, driven by advances in systemic oncology therapy, are increasing the incidence of skeletal-related complications requiring palliative vertebral stabilization to preserve mobility and quality of life. Oncologists and spinal surgeons have begun resorting to the procedure of vertebroplasty at an early stage of the treatment process in order to reduce pain and stabilize the patient’s spine without having to postpone radiotherapy and cancer treatments. With more and more oncology referral networks realizing that the procedure entails minimal risks and has a fast recovery process, vertebroplasty is increasingly used outside primary osteoporosis.

By Surgical Approach, Transpedicular dominated the Vertebroplasty And Kyphoplasty Market, while Extrapedicular is the fastest-growing segment.

The Transpedicular Approach was a key player in the Vertebroplasty and Kyphoplasty Market in 2025, holding a significant revenue share of 68.90%. The transpedicular approach continues to be the preferred pathway owing to the advantageous pathway via the vertebral pedicle that provides a safe route without involving any risks to the neighboring nerve and vascular tissues and allows accurate needle insertion in lumbar and lower thoracic vertebrae. The approach has been preferred by the surgeons due to its proven safety record, rich literature base, and its ability to work with unipedicular and bipedicular cement injection technique.

The Extrapedicular segment is anticipated to grow at the fastest rate during the forecast period 2026-2035, at a CAGR of 6.40%. Rising use of extrapedicular access in mid-thoracic vertebrae, where narrower pedicle dimensions limit instrumentation via the transpedicular route, is broadening the clinical applicability of this technique among interventional radiologists treating upper and mid-spine compression fractures. Growing physician training in costovertebral and parapedicular access methods, combined with improved needle and cannula design that reduces the risk of pleural or neural injury, continues to support faster adoption of extrapedicular approaches, particularly across specialized spine centers managing complex fracture morphology.

By End User, Hospitals dominated the Vertebroplasty And Kyphoplasty Market, while Ambulatory Surgical Centers is the fastest-growing segment.

Hospital accounted for 60.80% of revenue in the Vertebroplasty and Kyphoplasty Market in 2025. This is because hospitals are the leading care setting owing to their access to advanced imaging and anesthesia facilities and post-operative monitoring facilities required to manage complicated patients. In the hospital care setting, spine, oncology, and radiology team help in referring complicated cases where the patient needs vertebral body augmentation and interventional oncology in addition. Hospitals maintain strong relationships with medical device companies that provide next-generation navigation and cement delivery technology in addition.

Ambulatory Surgical Centers is one of the rapidly growing end-user segments and is projected to record a CAGR of 6.60% till 2035. In view of the fact that cost containment is now one of the primary concerns for the payers and patients prefer to get discharged on the same day coupled with quicker recoveries, such eligible and low-risk procedures are being shifted from the hospitals to the ASCs. There is added advantage of more efficient scheduling and reduced costs besides the increased reimbursement parity of vertebral augmentation procedures done at the ASCs.

Regional Analysis:

North America Vertebroplasty And Kyphoplasty Market Insights

North America dominated the global vertebroplasty and kyphoplasty market, accounting for approximately 39% of the market share in 2025. This leadership is attributed to the region’s advanced healthcare infrastructure, high adoption of minimally invasive spinal procedures, and increasing prevalence of osteoporosis and vertebral compression fractures. The presence of established medical device manufacturers, favorable reimbursement policies, and growing awareness of early diagnosis and treatment further supports market expansion. The United States remains the primary contributor to regional growth, driven by rising healthcare expenditure and technological advancements.

The US was the leading country within the North America Vertebroplasty And Kyphoplasty Market in 2025 with a market share of 86.40% of the regional market, driven by extensive domestic hospital and ambulatory surgical center networks, favorable outpatient reimbursement rates for balloon kyphoplasty, and continued clinical guideline support for early vertebral augmentation following acute fracture diagnosis. Canada is contributing to regional growth through its expanding public healthcare investment in minimally invasive spine procedures and growing adoption of advanced cement-delivery systems across major metropolitan hospital networks.

Europe Vertebroplasty And Kyphoplasty Market Insights

The Europe region was a major contributor to the Vertebroplasty And Kyphoplasty Market in 2025, expected to register steady growth for advanced bioactive cement solutions during the forecast period. This is attributed to the region's aging demographic profile, well-established spine surgery training infrastructure, and growing clinical emphasis on early intervention supported by strong quality-of-life outcome data comparing surgical augmentation against conservative management across multiple national health systems pursuing broader value-based care objectives.

Germany is one of the major markets in Europe owing to its strong hospital-based interventional radiology infrastructure and presence of leading spine device manufacturers serving both domestic and international customers. Other countries such as the United Kingdom, France, and Italy, home to established academic spine centers and growing private healthcare networks, are also contributing to market growth through expanding procedure volumes and increasing physician training in minimally invasive vertebral augmentation techniques.

Asia Pacific Vertebroplasty And Kyphoplasty Market Insights

The Asia Pacific Vertebroplasty And Kyphoplasty Market is expected to witness the fastest growth rate during the forecast period 2026-2035, registering a CAGR of 6.75%. The market growth is driven by rapidly expanding hospital infrastructure investment, rising osteoporosis prevalence among the region's large and aging population, and growing government focus on improving access to minimally invasive spine care across both urban tertiary centers and expanding secondary-city healthcare networks pursuing broader healthcare modernization strategies.

China is one of the main growth drivers in the Asia Pacific Vertebroplasty And Kyphoplasty Market, owing to its massive elderly population base and rapidly growing domestic medical device manufacturing capability supporting both local and export-oriented hospital customers. Japan and South Korea, both home to well-established interventional spine training programs, are also contributing to regional growth through expanding adoption of advanced navigation-assisted vertebral augmentation techniques and growing physician preference for early surgical intervention over extended conservative management.

Middle East & Africa and Latin America Vertebroplasty And Kyphoplasty Market Insights

Middle East & Africa and Latin American regions are gradually expanding vertebroplasty and kyphoplasty adoption as tertiary hospital investment grows across both regions, supported by increasing government healthcare modernization initiatives and growing physician training in minimally invasive spine procedures across major metropolitan referral centers.

Brazil is set to be a prominent Latin American market fueled by its expanding private hospital network and growing patient awareness of minimally invasive alternatives to open spinal fusion surgery. The Middle East & Africa region has the UAE and Saudi Arabia investing in advanced tertiary care infrastructure that is gradually increasing demand for vertebral augmentation systems across their expanding hospital and specialty spine center networks.

Market Dynamics:

Growth Drivers: Rising osteoporotic fracture burden and minimally invasive procedure adoption driving market growth

The rising global burden of osteoporotic vertebral compression fractures among aging populations, combined with growing physician and patient preference for minimally invasive day-care spine procedures, are among the primary drivers of the Vertebroplasty And Kyphoplasty Market. Vertebral augmentation provides a proven, cost-effective solution for restoring mobility and reducing chronic pain compared with prolonged conservative management, improving patient quality of life and reducing downstream disability-related healthcare costs across virtually every major healthcare system requiring efficient fracture management capability, from acute hospital care through outpatient ambulatory recovery pathways.

Technological advancements in cement chemistry and delivery-system engineering have significantly improved procedural safety, with recent innovations reducing cement leakage risk and improving vertebral height restoration outcomes across commercial device platforms. Rising integration of AI-assisted navigation and robotic alignment tools, growing clinical guideline support for early surgical intervention following acute fracture diagnosis, and continued reimbursement expansion for vertebral augmentation across developed and emerging healthcare markets are further supporting demand across the forecast period, as vertebroplasty and kyphoplasty continue displacing prolonged conservative pain management across an increasingly broad range of clinical care settings.

Restraints: Reimbursement variability and procedure-related complication risk limiting market expansion

Among the biggest hurdles that can affect the growth of the market is the inconsistent coverage of reimbursement for vertebroplasty procedures, which is dependent on the health care system or payers. Public and private payers cover the procedures inconsistently, which makes it difficult for healthcare providers to get the procedures done for patients in some areas even if early intervention is medically supported.

In addition to this, procedure-related adverse events, such as leakage of the cement used for treatment, the risk of adjacent level fractures and pulmonary cement embolism, still remain a challenge and need close scrutiny of the product in the post-marketing period to ensure only appropriate patients receive the procedure. Moreover, long timelines for regulatory approvals by bodies such as the FDA and EU-MDR, and volatility in the supply chain of PMMA monomers, etc., call for investments in these areas as well.

Opportunities: Expansion of oncology applications and cement engineering innovation creating new growth avenues

The increasing need for effective palliative stabilization solutions in oncology patients with vertebral metastases, the rise of AI-assisted and robotic-guided navigation platforms, and growing emphasis on bioactive cement innovation driven by rising biotechnology investment will provide ample growth opportunities in the Vertebroplasty And Kyphoplasty Market. The need for outpatient-compatible procedures that reduce hospital length of stay and overall treatment cost will ensure future growth as payers worldwide continue prioritizing value-based, cost-efficient care delivery models.

The scope for growth in the area of resorbable/osteocative cements that foster long-term bone integration among younger patients and osteopenic patients remains significant, supported by the increasing ambulatory surgical center capacity for vertebroplasty procedures on an outpatient basis. With investments in hospitals set to increase significantly in the developing nations of Asia-Pacific and Latin America and governments paying more attention to providing greater access to minimal spine procedures, the incremental demand would be anticipated to increase steadily.

Recent Developments:

• 2026: Xelite Biomed received U.S. FDA clearance for its SuperM-Fix Spinal Bone Cement (K251896), expanding the range of commercially available cement options for vertebral augmentation procedures across U.S. hospitals and ambulatory surgical centers.

• 2026: Medtronic and Merit Medical Systems expanded their distribution agreement for the FDA-cleared ViaVerte vertebral augmentation system, strengthening Medtronic's partnered go-to-market model while Merit continued supplying complementary Kyphon Xpander inflation syringes.

• 2025: Johnson & Johnson announced its intent to separate its DePuy Synthes orthopedics business into a standalone entity within 18 to 24 months, reshaping competitive positioning for its vertebral augmentation product portfolio.

• 2025: Stryker completed the divestiture of its spine business, which now operates as the independent entity VB Spine, intensifying competitive rivalry across balloon kyphoplasty and cement-delivery platforms.

• 2025: Globus Medical expanded its interventional spine portfolio with enhanced cement-delivery instrumentation designed to improve dosing precision during percutaneous vertebral augmentation procedures.

Vertebroplasty And Kyphoplasty Market Key Players are:

• Medtronic plc

• Stryker Corporation

• VB Spine

• Johnson & Johnson Services, Inc.

• Merit Medical Systems, Inc.

• Cardinal Health, Inc.

• Globus Medical, Inc.

• Alphatec Holdings, Inc.

• Becton, Dickinson and Company

• Zimmer Biomet Holdings, Inc.

• IZI Medical Products

• Spinal Elements, Inc.

• Teknimed SA

• Tecres S.p.A.

• G21 S.r.l.

• joimax GmbH

• Shanghai Kinetic Medical Limited Co., Ltd.

• Zavation Medical Products, LLC

• BIOPSYBELL S.R.L.

• SOMATEX Medical Technologies GmbH

Vertebroplasty And Kyphoplasty Market Report Scope: